Monitoring therapeutic response of human ovarian cancer to 17-DMAG by noninvasive PET imaging with (64)Cu-DOTA-trastuzumab.

Source:http://linkedlifedata.com/resource/pubmed/id/19440708

Download in:

View as

General Info

PMID
19440708